Agenus shared a post on LinkedIn:
“Garo Armen, Chairman and CEO of Agenus, recently joined Princess Dina on her podcast for a wide-ranging conversation on the promise of immunotherapy and the urgent need to improve how scientific innovation reaches patients.
The discussion explores the evolution of cancer immunotherapy, the challenge of cold tumors, the role of combination approaches, and the broader barriers that can delay patient access to potentially life-changing advances.
At Agenus, we remain committed to advancing immuno-oncology with a focus on reaching patients and tumor types that have not benefited enough from today’s therapies.
Watch the full conversation, now available on the Agenus website and below.”
Other articles about Immunotherapy on OncoDaily.